BioStrategy Partners

The Hidden Value of Data: Capturing Institutional Opportunity in the Age of AI
2025-12-16 10:00 - 12:00 (America/New_York) | Biolabs Advanced Therapeutics, 601 Walnut St. Floor 8, Philadelphia, Pennsylvania, United States
As artificial intelligence transforms biomedical research, data has become one of the most valuable yet inconsistently managed assets in healthcare and academic institutions. Much of its potential remains untapped, trapped in biobanks that are difficult to access, or siloed in legacy systems. Partnerships involving data are frequently being managed under outdated agreements that never anticipated its strategic worth. With no clear framework for valuing, assigning, or structuring data-driven partnerships, institutions faced with opportunity and risk. This session will bring together leaders from research and industry to discuss how to identify, protect, and responsibly capture the value of data in the AI era.

Speakers:

Tom Thornton, Vice President, Jefferson Ventures, Jefferson

Sangeeta Bardhan-Cook, PhD MBA, Chief Innovation Officer, Fox Chase Cancer Center

Michael Halaiko, CIPP/E , Baker Donelson

Location: Biolabs Advanced Therapeutics (601 Walnut St. Fl 8, Philadelphia, PA)

Your Tech Transfer Office as a Chief Navigation Office: Guiding Innovation from Lab to Impact
2026-02-12 15:00 - 17:00 | Biolabs Advanced Therapeutics, 601 Walnut St. Fl 8, Philadelphia, Pennsylvania, 19106, United States
As life sciences transactions grow more data-drive and partnership-oriented, the role of the Technology Transfer Office (TTO) is shifting. This session examines how forward-thinking offices are acting as Chief Navigation Offices to help guide inventors, startups, and industry partners through IP strategy, data and AI considerations, federal reporting requirements, and complex deal structures. Designed for entrepreneurs, corporate alliance professionals, and ecosystem leaders, the discussion will highlight how research institutions help translate discovery into scalable products, partnerships, and commercial impact.

Zev Sunleaf, VP, Technology Transfer & Commercialization (Moderator), Children’s Hospital of Philadelphia

Adam Van Dyke, PhD, AVP, Innovation & Translational Development, Fox Chase Cancer Center

Justin Crotty, PhD, JD, Partner, Saul Ewing LLP

Greg Jackson, PhD, Executive Vice President, Life Sciences Greenhouse Investments
